TB Vaccine Phase 3 Trial Launched, as WHO Makes Case for Investing in Screening and Prevention

Health Policy Watch
Mar 20, 2024

TB Vaccine Phase 3 Trial Launched, as WHO Makes Case for Investing in Screening and Prevention


A Phase 3 trial of a tuberculosis vaccine candidate has been launched in South Africa, according to the Bill & Melinda Gates Medical Research Institute (Gates MRI).

The candidate vaccine – referred to as  M72/AS01E – “could potentially become the first vaccine to help prevent pulmonary TB in adolescents and adults, the most common form of the disease, and the first new TB vaccine in over a century”, according to Gates MR, which is sponsoring the trial along with support from Wellcome Trust.